Medicare Enrolled
Dr. Rodolfo Sotolongo, MD
Cardiovascular Disease · Beaumont, TX
Practice pattern: Remote Monitoring— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sotolongo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sotolongo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sotolongo
Dr. Rodolfo Sotolongo is a cardiovascular disease in Beaumont, TX, with 19 years in practice. Based on federal Medicare data, Dr. Sotolongo performed 22,394 Medicare services across 4,525 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sotolongo received a total of $7,901 from 32 pharmaceutical and/or device companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sotolongo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $7,901 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,394
Medicare services
Top 1% in TX for cardiovascular disease
4,525
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,179 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 6,113 | $30 | $80 |
| Remote patient monitoring management, 20 min/month | 3,895 | $36 | $75 |
| Remote patient monitoring device, 30 days | 3,364 | $35 | $200 |
| Contrast dye for imaging (iodine-based) | 2,316 | $0 | $1 |
| Electrocardiogram (EKG), 12-lead | 1,398 | $10 | $80 |
| Office visit, established patient (30-39 min) | 1,258 | $89 | $150 |
| Chronic care management, additional 20 min/month | 951 | $36 | $75 |
| Chronic care management, first 20 min/month | 538 | $47 | $75 |
| Echocardiogram, transthoracic | 434 | $117 | $957 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 177 | $28 | $60 |
| Prothrombin time test (blood clotting) | 155 | $4 | $13 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 133 | $66 | $150 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 131 | $11 | $125 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 128 | $15 | $35 |
| Ultrasound of both sides of head and neck blood flow | 115 | $135 | $450 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 109 | $20 | $62 |
| Remote pacemaker/defibrillator monitoring, 90 days | 108 | $16 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 106 | $7 | $30 |
| Office visit, established patient, complex (40-54 min) | 97 | $132 | $185 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 97 | $14 | $50 |
| New patient office visit (45-59 min) | 83 | $114 | $200 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 74 | $20 | $41 |
| Regadenoson injection (Lexiscan) for heart stress test | 72 | $28 | $70 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 58 | $27 | $130 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 55 | $7 | $25 |
| Remote pacemaker monitoring, 90 days | 48 | $23 | $70 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $36 | $75 |
| Ultrasonic guidance for blood vessel access | 43 | $29 | $205 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 36 | $19 | $40 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 36 | $629 | $1,300 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $123 | $430 |
| Sleep study including heart rate, breathing, and sleep time | 31 | $84 | $160 |
| Programming of dual lead pacemaker system | 24 | $49 | $120 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $42 | $400 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $303 | $1,700 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 18 | $13 | $25 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $70 | $325 |
| Blood draw (venipuncture) | 15 | $8 | $15 |
| Programming of multiple lead implantable defibrillator system | 13 | $81 | $190 |
| Cardiac catheterization | 13 | $789 | $2,500 |
| Ultrasound of heart, follow-up | 12 | $65 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.4% high complexity
12.8% medium
83.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,901
Total received (2018-2024)
Avg $1,129/year across 7 years
Top 37% in TX for cardiovascular disease
32
Companies
336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,901 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$975
2023$815
2022$1,163
2021$862
2020$979
2019$955
2018$2,151
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BOSTON SCIENTIFIC CORPORATION
$1,805
Boston Scientific Corporation
$1,616
Edwards Lifesciences Corporation
$792
Janssen Pharmaceuticals, Inc
$582
Endologix LLC
$355
Medtronic Vascular, Inc.
$326
Biosense Webster, Inc.
$316
E.R. Squibb & Sons, L.L.C.
$261
Abbott Laboratories
$217
Inari Medical, Inc.
$201
Novartis Pharmaceuticals Corporation
$164
Bolton Medical Inc
$149
PFIZER INC.
$140
Merck Sharp & Dohme LLC
$117
Philips Electronics North America Corporation
$90
Tactile Systems Technology Inc
$89
Amarin Pharma Inc.
$89
Baxter Healthcare
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
InfoBionic, Inc
$63
Esperion Therapeutics, Inc.
$54
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$46
ARBOR PHARMACEUTICALS, INC.
$45
Merck Sharp & Dohme Corporation
$43
Novo Nordisk Inc
$38
Aziyo Biologics, Inc.
$37
Amgen Inc.
$33
Alnylam Pharmaceuticals Inc.
$26
Cardiovascular Systems Inc.
$24
LivaNova USA, Inc.
$16
Ethicon US, LLC
$16
Braemar Manufacturing, LLC
$14
Top 3 companies account for 53.3% of total payments
Associated products mentioned in payments ›
AMPLATZER · ASSURITY · Alto Abdominal Stent Graft System · Amplia MRI · AngioJet Ultra 5000A · Azure · BodyGuardian · CARDIOMEMS · CARTO 3 · CHANTIX · Cardiac Monitoring Suite · Carto 3 System · Circulatory Support · Claria MRI · CoreValve Evolut · Corlanor · DYNAGEN · Diamondback Peripheral · ECM · ECM Patch · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · ETHICON · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FINELINE · FLEXITOUCH · FLOWTRIEVER CATHETER · GENERAL ANGIOPLASTY · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL ULTRASOUND · GENERAL VASCULAR INTERVENTION · GENERAL - BRADY · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL - ULTRASOUND · GENERAL ATHERECTOMY · GENERAL BRADY · GENERAL ULTRASOUND · GENERAL VASCULAR INTERVENTION · General - Atherectomy · General - Tachy · General - Therapies · Hillrom - Carnation Ambulatory Monitor · IGT_D Therapy · INGEVITY · JARDIANCE · JETSTREAM · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MOMENTUM · MYLUX · MoMe Kardia · NEXLETOL · ONPATTRO · Ozempic · PRADAXA · Percepta · Pouch · RESONATE · ROTALINK · Repatha · Reveal LINQ · S · SQ RX PULSE GENERATOR · SQ-RX PULSE GENERATOR · SQRX PULSE GENERATOR · TREO ABDOMINAL STENT-GRAFT SYSTEM · VERQUVO · VIGILANT · VNS Therapy · Varithena Administration Pack · Vascepa · VenaSeal · Viva · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $35 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
17
Per 100K population
6.7
County median income
$59,934
Nearest hospital
CHRISTUS SOUTHEAST TEXAS- ST ELIZABETH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sotolongo is a remote monitoring specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sotolongo experienced with management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes?
Based on Medicare claims data, Dr. Sotolongo performed 6,113 management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sotolongo receive payments from pharmaceutical companies?
Yes. Dr. Sotolongo received a total of $7,901 from 32 companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sotolongo's costs compare to other cardiovascular diseases in Beaumont?
Dr. Sotolongo's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sotolongo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Beaumont
Browse cardiovascular diseases in Beaumont ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology